<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Levonorgestrel</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00367</strong>&#160; (APRD00106, APRD00754, DB00506)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved, investigational</td></tr><tr><th>Description</th><td><p>A synthetic progestational hormone with actions similar to those of progesterone and about twice as potent as its racemic or (+-)-isomer (norgestrel). It is used for contraception, control of menstrual disorders, and treatment of endometriosis. It is usually supplied in a racemic mixture (Norgestrel, 6533-00-2). Only the levonorgestrel isomer is active. Levonorgestrel is marketed mostly as a combination oral contraceptive under several brand names such as Alesse, Triphasil, and Min-Ovral.</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00367/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00367/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00367.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00367.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00367.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00367.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00367.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00367">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one</td><td><span class="wishart wishart-not-available">Not Available</span></td><td>IUPAC</td></tr><tr><td>18-Methylnorethisterone</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>d(-)-Norgestrel</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Levonorgestrel</td><td><span class="wishart wishart-not-available">Not Available</span></td><td>BAN, DCIT, USAN, BP 2011, Ph. Eur. 7, Ph. Int. 4, USP 34</td></tr><tr><td>L&#233;vonorgestrel</td><td><span class="wishart wishart-not-available">Not Available</span></td><td>DCF</td></tr><tr><td>Levonorgestrelum</td><td>Latin</td><td>INN</td></tr></tbody></table></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Jadelle</td><td>Bayer</td></tr><tr><td>Levonelle</td><td>Bayer</td></tr><tr><td>Medonor</td><td>Medopharm</td></tr><tr><td>Microlut</td><td>Bayer</td></tr><tr><td>Microval</td><td>Wyeth</td></tr><tr><td>Mirena</td><td>Bayer</td></tr><tr><td>Neogest</td><td>Schering</td></tr><tr><td>Next Choice</td><td>Watson</td></tr><tr><td>Norgeston</td><td>Bayer</td></tr><tr><td>NorLevo</td><td>Bayer</td></tr><tr><td>Norplant</td><td>Bayer</td></tr><tr><td>Plan B</td><td>Teva</td></tr><tr><td>Postinor</td><td>Gedeon Richter</td></tr><tr><td>Skyla</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="mixtures"><thead><tr><th>Brand Name</th><th>Ingredients</th></tr></thead><tbody><tr><td>Alesse</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Amethyst</td><td>Levonorgestrel + Ethinyl Estradiol</td></tr><tr><td>Aviane</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Enpresse</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Jolessa</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Lessina</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Levlen</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Levora</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Lo/Ovral</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Logynon</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Logynon ED</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Lutera</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Lybrel</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Microgyn</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Microgynon 30</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Microgynon 30 ED</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Min-Ovral</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Nordette</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Nordiol</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Ovranette</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Portia</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Preven</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Quartette</td><td>Levonorgestrel/Ethinyl Estradiol + Ethinyl Estradiol</td></tr><tr><td>Quasense</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Rigevidon</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Seasonale</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Seasonique</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Sronyx</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Stediril</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Tri-Levlen 21</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Trifeme 28</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Trinordiol</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Triphasil</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Triquilar</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr><tr><td>Trivora</td><td>Ethinyl Estradiol + Levonorgestrel</td></tr></tbody></table></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/contraceptives-oral-synthetic">Contraceptives, Oral, Synthetic</a></li>
<li><a href="/mesh/contraceptive-agents-female">Contraceptive Agents, Female</a></li>
<li><a href="/mesh/contraceptive-agents">Contraceptive Agents</a></li></ul></td></tr><tr><th>CAS number</th><td>797-63-7</td></tr><tr><th>Weight</th><td>Average: 312.4458<br>Monoisotopic: 312.20893014</td></tr><tr><th>Chemical Formula</th><td>C<sub>21</sub>H<sub>28</sub>O<sub>2</sub></td></tr><tr><th>InChI Key</th><td>WWYNJERNGUHSAO-XUDSTZEESA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">(1S,2R,10R,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxytetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one</div></td></tr><tr><th>SMILES</th><td><div class="wrap">[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Lipids</td></tr><tr><th>Class</th><td>Steroids and Steroid Derivatives</td></tr><tr><th>Subclass</th><td>Ketosteroids</td></tr><tr><th>Direct parent</th><td>Ketosteroids</td></tr><tr><th>Alternative parents</th><td>Hydroxysteroids; Estrogens and Derivatives; Ynones; Tertiary Alcohols; Cyclic Alcohols and Derivatives; Polyamines</td></tr><tr><th>Substituents</th><td>ynone; tertiary alcohol; cyclic alcohol; ketone; polyamine; alcohol; carbonyl group</td></tr><tr><th>Classification description</th><td>This compound belongs to the ketosteroids. These are steroid derivatives comprising a ketone group attached to steroid skeleton.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For the treatment of menopausal and postmenopausal disorders and alone or in combination with other hormones as an oral contraceptive.</td></tr><tr><th>Pharmacodynamics</th><td>Levonorgestrel is a progestin or a synthetic form of the naturally occurring female sex hormone, progesterone. In a woman's normal menstrual cycle, an egg matures and is released from the ovaries (ovulation). The ovary then produces progesterone, preventing the release of further eggs and priming the lining of the womb for a possible pregnancy. If pregnancy occurs, progesterone levels in the body remain high, maintaining the womb lining. If pregnancy does not occur, progesterone levels in the body fall, resulting in a menstrual period. Levonorgestrel tricks the body processes into thinking that ovulation has already occurred, by maintaining high levels of the synthetic progesterone. This prevents the release of eggs from the ovaries.</td></tr><tr><th>Mechanism of action</th><td>Binds to the progesterone and estrogen receptors. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once bound to the receptor, progestins like levonorgestrel will slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH (luteinizing hormone) surge.</td></tr><tr><th>Absorption</th><td>Levonorgestrel is not subjected to a "first-pass" effect and is virtually 100% bioavailable.</td></tr><tr><th>Volume of distribution</th><td><ul>
	<li>260 L [Healthy Female Volunteers under Fasting Conditions]</li>
	<li>1.8 L/kg</li>
</ul></td></tr><tr><th>Protein binding</th><td>55%</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Hepatic</p></td></tr><tr><th>Route of elimination</th><td>About 45% of levonorgestrel and its metabolites are excreted in the urine and about 32% are excreted in feces, mostly as glucuronide conjugates.</td></tr><tr><th>Half life</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Clearance</th><td><ul>
	<li>7.7 +/- 2.7 L/h [Healthy Female Volunteers under Fasting Conditions]</li>
</ul></td></tr><tr><th>Toxicity</th><td>LD50 &gt;5000 mg/kg (orally in rats)</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>1.0</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.9453</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              +
        </td>
        <td>0.8094</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.6648</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Inhibitor
        </td>
        <td>0.5</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8382</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.7697</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7904</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.9165</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Substrate</td>
        <td>0.7239</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9045</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.907</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9232</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Inhibitor</td>
        <td>0.8994</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.7772</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.516</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.9132
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.9328
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.9814
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          1.8264 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.8205
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.7408
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Wyeth pharmaceuticals inc</li>
<li>Population council</li>
<li>Population council center for biomedical research</li>
<li>Bayer healthcare pharmaceuticals inc</li>
<li>Watson laboratories inc</li>
<li>Duramed pharmaceuticals inc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.3m.com">3M Health Care</a></li>
<li><a href="http://orders.a-smeds.com">A-S Medication Solutions LLC</a></li>
<li>Barr Pharmaceuticals</li>
<li><a href="http://www.bayerhealthcare.com">Bayer Healthcare</a></li>
<li><a href="http://www.berlex.com">Berlex Labs</a></li>
<li><a href="http://www.cardinal.com">Cardinal Health</a></li>
<li>Chemical Works Of Gedeon Richter Ltd.</li>
<li>Dept Health Central Pharmacy</li>
<li><a href="http://www.drxdispensing.com">Dispensing Solutions</a></li>
<li><a href="http://www.dhscorp.com">Diversified Healthcare Services Inc.</a></li>
<li><a href="http://www.duramed.ca">Duramed</a></li>
<li><a href="http://www.gynetics.be">Gynetics Inc.</a></li>
<li><a href="http://www.patheon.com">Patheon Inc.</a></li>
<li>PCAS Finland Oy</li>
<li><a href="http://www.pdrx.com">PD-Rx Pharmaceuticals Inc.</a></li>
<li>Pharmaceutical Utilization Management Program VA Inc.</li>
<li><a href="http://www.pplpho.org">Physician Partners Ltd.</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li>Professional Co.</li>
<li><a href="http://www.rebelrx.com">Rebel Distributors Corp.</a></li>
<li>Redpharm Drug</li>
<li><a href="http://www.schering.de">Schering Corp.</a></li>
<li>SCS Pharmaceuticals</li>
<li><a href="http://www.tevapharm.com">Teva Pharmaceutical Industries Ltd.</a></li>
<li><a href="http://www.watson.com">Watson Pharmaceuticals</a></li>
<li>Womens Capital Corp.</li>
<li><a href="http://www.wyeth.com">Wyeth Pharmaceuticals</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Insert, extended release</td><td>Intrauterine</td><td></td></tr><tr><td>Tablet</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB01351">Amobarbital</a></td><td>Phenobarbital decreases the effect of levonorgestrel</td></tr><tr><td><a href="/drugs/DB01352">Aprobarbital</a></td><td>Phenobarbital decreases the effect of levonorgestrel</td></tr><tr><td><a href="/drugs/DB06697">Artemether</a></td><td>Artemether may decrease the effectiveness of levonorgestrel by increasing its metabolism via CYP3A4. Consider an alternate non-hormonal means of contraception during artemether therapy.</td></tr><tr><td><a href="/drugs/DB00307">Bexarotene</a></td><td>Bexarotene may decrease the serum concentration of Contraceptives (Progestins). Since bexarotene is teratogenic and can lower serum concentrations of levonorgestrel, it is advised that women of childbearing potential use two forms of contraception (including at least one non-hormonal form).</td></tr><tr><td><a href="/drugs/DB00237">Butabarbital</a></td><td>Phenobarbital decreases the effect of levonorgestrel</td></tr><tr><td><a href="/drugs/DB00241">Butalbital</a></td><td>Phenobarbital decreases the effect of levonorgestrel</td></tr><tr><td><a href="/drugs/DB01353">Butethal</a></td><td>Phenobarbital decreases the effect of levonorgestrel</td></tr><tr><td><a href="/drugs/DB00564">Carbamazepine</a></td><td>Carbamazepine may decrease the contraceptive effect of levonorgestrel.</td></tr><tr><td><a href="/drugs/DB00930">Colesevelam</a></td><td>Bile Acid Sequestrants may decrease the serum concentration of Contraceptives (Progestins). Administer oral progestin-containing contraceptives at least 1-4 hours prior to or 4-6 hours after administration of a bile acid sequestrant. Consider alternatives in order to avoid this combination when possible, due to the risk for impaired contraceptive effectiveness. </td></tr><tr><td><a href="/drugs/DB01341">Dihydroquinidine barbiturate</a></td><td>Phenobarbital decreases the effect of levonorgestrel</td></tr><tr><td><a href="/drugs/DB00754">Ethotoin</a></td><td>Phenytoin decreases the contraceptive effect</td></tr><tr><td><a href="/drugs/DB01320">Fosphenytoin</a></td><td>Phenytoin decreases the contraceptive effect</td></tr><tr><td><a href="/drugs/DB01354">Heptabarbital</a></td><td>Phenobarbital decreases the effect of levonorgestrel</td></tr><tr><td><a href="/drugs/DB01355">Hexobarbital</a></td><td>Phenobarbital decreases the effect of levonorgestrel</td></tr><tr><td><a href="/drugs/DB00532">Mephenytoin</a></td><td>Phenytoin decreases the contraceptive effect</td></tr><tr><td><a href="/drugs/DB00474">Methohexital</a></td><td>Phenobarbital decreases the effect of levonorgestrel</td></tr><tr><td><a href="/drugs/DB00849">Methylphenobarbital</a></td><td>Phenobarbital decreases the effect of levonorgestrel</td></tr><tr><td><a href="/drugs/DB00312">Pentobarbital</a></td><td>Phenobarbital decreases the effect of levonorgestrel</td></tr><tr><td><a href="/drugs/DB01174">Phenobarbital</a></td><td>Phenobarbital decreases the effect of levonorgestrel</td></tr><tr><td><a href="/drugs/DB00252">Phenytoin</a></td><td>Phenytoin decreases the contraceptive effect</td></tr><tr><td><a href="/drugs/DB00794">Primidone</a></td><td>Phenobarbital decreases the effect of levonorgestrel</td></tr><tr><td><a href="/drugs/DB01346">Quinidine barbiturate</a></td><td>Phenobarbital decreases the effect of levonorgestrel</td></tr><tr><td><a href="/drugs/DB00418">Secobarbital</a></td><td>Phenobarbital decreases the effect of levonorgestrel</td></tr><tr><td><a href="/drugs/DB00306">Talbutal</a></td><td>Phenobarbital decreases the effect of levonorgestrel</td></tr><tr><td><a href="/drugs/DB00599">Thiopental</a></td><td>Thiopental may decrease the effect of Levonorgestrel. Contraceptive failure may occur. Alternative nonhomomonal contraception should be used during concomitant therapy. </td></tr><tr><td><a href="/drugs/DB00755">Tretinoin</a></td><td>Oral Tretinoin may decrease the effect of oral contraceptive, Levonorgestrel. An alternate form of contraception should be used during concomitant therapy. </td></tr><tr><td><a href="/drugs/DB00682">Warfarin</a></td><td>Levonorgestrel may alter the anticoagulant effect of warfarin. Concomitant therapy should be avoided. Monitor for changes in coagulation status if levonorgestrel is initiated, discontinued or dose changed.</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><ul><li>Avoid alcohol.</li>
<li>Avoid excessive quantities of coffee or tea (Caffeine).</li>
<li>Increase dietary intake of magnesium, folate, vitamin B6, B12, and/or consider taking a multivitamin.</li>
<li>Take at the same time everyday.</li>
<li>Take with food.</li></ul></td></tr></tbody></table>